PolyPid Ltd. (PYPD) Financials
PYPD Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 15.2 million | 9.8 million |
| March 31, 2026 | 19.2 million | 10.4 million |
| Dec. 31, 2025 | 22.3 million | 11.3 million |
| Sept. 30, 2025 | 26.8 million | 11.5 million |
PYPD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | ? | ? |
| March 31, 2026 | ? | ? |
| Dec. 31, 2025 | ? | ? |
| Sept. 30, 2025 | ? | ? |
PYPD Net Income
No data available :(
PYPD Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 6.6 million | - | 1.6 million |
| March 31, 2026 | 11.1 million | - | 383000 |
| Dec. 31, 2025 | 12.9 million | - | 1.8 million |
| Sept. 30, 2025 | 19.0 million | - | 1.9 million |
PYPD Shares Outstanding
PYPD Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 6.1 million | 1.7 million | 459000 |
| March 31, 2026 | - | 5.8 million | 2.0 million | 414000 |
| Dec. 31, 2025 | - | 6.2 million | 2.3 million | 556000 |
| Sept. 30, 2025 | - | 5.3 million | 2.2 million | 432000 |
PYPD Cost of Revenue
No data available :(
PYPD
Price: $4.74
52 week price:
Earnings Per Share: -1.72 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 407700
Market Capitalization: 91.7 million